Balyasny Asset Management’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-13,883
| Closed | -$87K | – | 1968 |
|
|
2020
Q4 | $87K | Buy |
+13,883
| New | +$87K | ﹤0.01% | 1097 |
|
|
2020
Q2 | – | Sell |
-339,869
| Closed | -$1.07M | – | 1413 |
|
|
2020
Q1 | $1.07M | Buy |
+339,869
| New | +$1.07M | 0.01% | 630 |
|
|
2018
Q3 | – | Sell |
-15,800
| Closed | -$161K | – | 1852 |
|
|
2018
Q2 | $161K | Buy |
15,800
+2,300
| +17% | +$23.4K | ﹤0.01% | 1487 |
|
|
2018
Q1 | $176K | Buy |
+13,500
| New | +$176K | ﹤0.01% | 1589 |
|
|
2017
Q3 | – | Sell |
-350,000
| Closed | -$8.44M | – | 1885 |
|
|
2017
Q2 | $8.44M | Sell |
350,000
-48,850
| -12% | -$1.18M | 0.03% | 489 |
|
|
2017
Q1 | $7.68M | Buy |
398,850
+148,550
| +59% | +$2.86M | 0.04% | 506 |
|
|
2016
Q4 | $3.86M | Buy |
+250,300
| New | +$3.86M | 0.02% | 601 |
|